# Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

> **NCT00750659** · PHASE2 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Stem Cell Transplantation

## Interventions

- **DRUG:** Nilotinib

## Key facts

- **NCT ID:** NCT00750659
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750659, "Nilotinib Pre and Post Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00750659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*